Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Nucleic Acids Research / High-throughput screen of 100 000 small molecules in C9ORF72 ALS neurons identifies spliceosome modulators that mobilize G4C2 repeat RNA into nuclear export and repeat associated non-canonical translation

Title: Nucleic Acids Research / High-throughput screen of 100 000 small molecules in C9ORF72 ALS neurons identifies spliceosome modulators that mobilize G4C2 repeat RNA into nuclear export and repeat associated non-canonical translation
Authors: Luteijn, Maartje J; Bhaskar, Varun; Trojer, Dominic; Schürz, Melanie; Mahboubi, Hicham; Handl, Cornelia; Pizzato, Nicolas; Pfeifer, Martin; Dafinca, Ruxandra; Voshol, Hans; Giorgetti, Elisa; Manneville, Carole; Garnier, Isabelle P M; Müller, Matthias; Zeng, Fanning; Buntin, Kathrin; Markwalder, Roger; Schröder, Harald; Weiler, Jan; Khar, Dora; Schuhmann, Tim; Groot-Kormelink, Paul J; Keller, Caroline Gubser; Farmer, Pierre; MacKay, Angela; Beibel, Martin; Roma, Guglielmo; D’Ario, Giovanni; Merkl, Claudia; Schebesta, Michael; Hild, Marc; Elwood, Fiona; Vahsen, Björn F; Ripin, Nina; Clery, Antoine; Allain, Frederic; Labow, Mark; Gabriel, Daniela; Chao, Jeffrey A; Talbot, Kevin; Nash, Mark; Hunziker, Jürg; Meisner-Kober, Nicole C
Publisher Information: Oxford University Press
Publication Year: 2025
Collection: ePLUS - Open Access Publikationsserver der Universität Salzburg
Description: An intronic G4C2 repeat expansion in the C9ORF72 gene is the major known cause for Amyotrophic Lateral Sclerosis (ALS), with current evidence for both, loss of function and pathological gain of function disease mechanisms. We screened 96 200 small molecules in C9ORF72 patient iPS neurons for modulation of nuclear G4C2 RNA foci and identified 82 validated hits, including the Brd4 inhibitor JQ1 as well as novel analogs of Spliceostatin-A, a known modulator of SF3B1, the branch point binding protein of the U2-snRNP. Spliceosome modulation by these SF3B1 targeted compounds recruits SRSF1 to nuclear G4C2 RNA, mobilizing it from RNA foci into nucleocytoplasmic export. This leads to increased repeat-associated non-canonical (RAN) translation and ultimately, enhanced cell toxicity. Our data (i) provide a new pharmacological entry point with novel as well as known, publicly available tool compounds for dissection of C9ORF72 pathobiology in C9ORF72 ALS models, (ii) allowing to differentially modulate RNA foci versus RAN translation, and (iii) suggest that therapeutic RNA foci elimination strategies warrant caution due to a potential storage function, counteracting translation into toxic dipeptide repeat polyproteins. Instead, our data support modulation of nuclear export via SRSF1 or SR protein kinases as possible targets for future pharmacological drug discovery. ; European Funds for Regional Development EFRE/IWB 20102-F1900731-KZP WISS2025 F2200397-KZP WISS2025 P1812596
Document Type: article in journal/newspaper
File Description: text/html
Language: English
ISSN: 1362-4962
Relation: vignette : https://eplus.uni-salzburg.at/titlepage/urn/urn:nbn:at:at-ubs:3-40254/128; local:99150005010103331; system:AC17827312
DOI: 10.1093/nar/gkaf253
Availability: https://doi.org/10.1093/nar/gkaf253; https://eplus.uni-salzburg.at/doi/10.1093/nar/gkaf253; https://resolver.obvsg.at/urn:nbn:at:at-ubs:3-40254
Rights: CC BY-NC 4.0
Accession Number: edsbas.AD83ACA3
Database: BASE